EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent Advances in Natural Products for Cancer Immunotherapy

Taiqing Liu, Jinhua Zhao, Ziying Yao, Jingxuan Zhou, Hanlin Gong, Zhaohui Jin, Zhiyao He

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70218 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Taiqing Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Immunotherapy, Biological Products, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 195 Literaturangaben. Gefördert von: Science and Technology program of Xizang Autonomous Region, Science and Technology program of Chengdu, Sichuan Science and Technology program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural products (NPs) have long been a cornerstone of anticancer drug discovery; yet their systematic integration into cancer immunotherapy remains limited. This review offers a mechanistic and classification‐based perspective, organizing representative NPs, specifically polysaccharides, flavonoids, terpenoids, and alkaloids—according to their distinct immunomodulatory mechanisms within the tumor immune microenvironment. We elucidate how NPs reshape the immune landscape throughout the process of cancer immunoediting, enhancing immune cell infiltration, activating effector responses, and reprogramming cytokine signaling networks. In addition to their potential as single agents, we highlight emerging combination strategies in which NPs synergize with immune checkpoint inhibitors or serve as payloads in antibody–drug conjugates to overcome immunosuppression and therapeutic resistance. By integrating insights across structural classes and functional pathways, this review establishes a cohesive framework linking NP pharmacology with immuno‐oncology, aiming to guide the rational design of NP‐based combination immunotherapies and accelerate their clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyBiological ProductsNeoplasmsHumansAnimalsTumor MicroenvironmentTerpenesAlkaloidsFlavonoidsPolysaccharidesAntineoplastic Agents

Stichwörter der Autor:innen

alkaloidscancer immunotherapyflavonoidsnatural productspolysaccharidesterpenoids

Substanzen

Biological ProductsTerpenesAlkaloidsFlavonoidsPolysaccharidesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial T…
  • Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, China.

Förderung

  • Science and Technology program of Xizang Autonomous Region
  • Science and Technology program of Chengdu
  • Sichuan Science and Technology program

Zitieren

APA

Liu, T., Zhao, J., Yao, Z., Zhou, J., Gong, H., Jin, Z., & He, Z. (2026). Recent Advances in Natural Products for Cancer Immunotherapy. Phytotherapy Research. https://doi.org/10.1002/ptr.70218

Vancouver

Liu T, Zhao J, Yao Z, Zhou J, Gong H, Jin Z, et al. Recent Advances in Natural Products for Cancer Immunotherapy. Phytotherapy Research. 2026. doi:10.1002/ptr.70218

BibTeX
@article{Liu2026,
  author = {Liu, Taiqing and Zhao, Jinhua and Yao, Ziying and Zhou, Jingxuan and Gong, Hanlin and Jin, Zhaohui and He, Zhiyao},
  title = {Recent Advances in Natural Products for Cancer Immunotherapy},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70218}
}
Kostenlos starten →